Wells Fargo & Company MN lowered its position in Healthequity Inc (NASDAQ:HQY) by 38.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 601,933 shares of the company’s stock after selling 376,124 shares during the quarter. Wells Fargo & Company MN owned about 0.97% of Healthequity worth $45,205,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. New York State Teachers Retirement System grew its holdings in shares of Healthequity by 2.5% during the second quarter. New York State Teachers Retirement System now owns 34,957 shares of the company’s stock worth $2,625,000 after purchasing an additional 841 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its holdings in shares of Healthequity by 10.7% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 26,521 shares of the company’s stock worth $1,992,000 after purchasing an additional 2,560 shares in the last quarter. Rockefeller Capital Management L.P. purchased a new position in shares of Healthequity during the second quarter worth about $179,000. Alps Advisors Inc. grew its holdings in shares of Healthequity by 26.8% during the second quarter. Alps Advisors Inc. now owns 10,355 shares of the company’s stock worth $483,000 after purchasing an additional 2,188 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. grew its holdings in shares of Healthequity by 16.9% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 97,854 shares of the company’s stock worth $7,349,000 after purchasing an additional 14,131 shares in the last quarter. 95.38% of the stock is owned by institutional investors.

Several research analysts have recently commented on HQY shares. JPMorgan Chase & Co. started coverage on Healthequity in a report on Tuesday, April 24th. They set an “overweight” rating and a $69.00 price objective for the company. Zacks Investment Research lowered Healthequity from a “buy” rating to a “hold” rating in a report on Saturday, May 12th. ValuEngine raised Healthequity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, May 22nd. Bank of America started coverage on Healthequity in a report on Wednesday, May 23rd. They set a “buy” rating and a $83.00 price objective for the company. Finally, Cantor Fitzgerald lowered Healthequity from an “overweight” rating to a “neutral” rating and set a $65.00 price objective for the company. in a report on Wednesday, May 30th. Three analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $77.73.

In related news, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $73.93, for a total value of $702,335.00. Following the completion of the sale, the vice president now owns 111,500 shares in the company, valued at approximately $8,243,195. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Frank Medici sold 6,904 shares of the business’s stock in a transaction that occurred on Friday, July 13th. The stock was sold at an average price of $80.40, for a total value of $555,081.60. Following the completion of the sale, the director now owns 17,649 shares of the company’s stock, valued at approximately $1,418,979.60. The disclosure for this sale can be found here. Insiders sold a total of 57,100 shares of company stock valued at $4,457,965 in the last 90 days. 4.00% of the stock is currently owned by corporate insiders.

NASDAQ:HQY opened at $87.05 on Friday. The company has a market capitalization of $5.12 billion, a P/E ratio of 161.20, a PEG ratio of 3.43 and a beta of 1.37. Healthequity Inc has a 1-year low of $40.21 and a 1-year high of $88.30.

Healthequity (NASDAQ:HQY) last released its earnings results on Monday, June 4th. The company reported $0.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.09. The company had revenue of $69.90 million during the quarter, compared to the consensus estimate of $68.81 million. Healthequity had a return on equity of 13.47% and a net margin of 22.91%. Healthequity’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 EPS. analysts expect that Healthequity Inc will post 0.72 earnings per share for the current fiscal year.

Healthequity Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: Asset Allocation Models, Which is Right For You?

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.